BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hügle B, van Dijkhuizen EHP. MTX intolerance in children and adolescents with juvenile idiopathic arthritis. Rheumatology 2020;59:1482-8. [DOI: 10.1093/rheumatology/keaa139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Klotsche J, Klein A, Niewerth M, Hoff P, Windschall D, Foeldvari I, Haas JP, Horneff G, Minden K. Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis. Arthritis Res Ther 2021;23:118. [PMID: 33863349 DOI: 10.1186/s13075-021-02492-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kaya Akca U, Farisogullari B, Yardimci GK, Sag E, Atalay E, Kasap Cuceoglu M, Basaran O, Kilic L, Ozen S, Bilginer Y. Real-world data on MTX tolerance with regimens used in children versus adults. Clin Rheumatol 2021. [PMID: 34218394 DOI: 10.1007/s10067-021-05802-8] [Reference Citation Analysis]
3 Rebane K, Tuomi AK, Kautiainen H, Peltoniemi S, Glerup M, Aalto K. Abdominal pain in Finnish young adults with juvenile idiopathic arthritis. Scand J Gastroenterol 2022;:1-6. [PMID: 35546660 DOI: 10.1080/00365521.2022.2072691] [Reference Citation Analysis]